Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment

Research output: Contribution to journalArticleAcademic

56 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)719-726
Number of pages8
JournalOncologist
Volume12
DOIs
Publication statusPublished - 2007

Research programs

  • EMC MM-03-86-08

Cite this